DrugPatentWatch Database Preview
Drugs in Development Information for Uridine-5'-Diphosphate
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Uridine-5'-Diphosphate?
Uridine-5'-Diphosphate is an investigational drug.
There have been 31 clinical trials for Uridine-5'-Diphosphate.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2018.
The most common disease conditions in clinical trials are Bipolar Disorder, Depression, and HIV Infections. The leading clinical trial sponsors are National Cancer Institute (NCI), National Institute of Mental Health (NIMH), and Wellstat Therapeutics.
There are eleven US patents protecting this investigational drug and five hundred and thirteen international patents.
Summary for Uridine-5'-Diphosphate
| US Patents | 11 |
| International Patents | 513 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2018-02-01) |
| Vendors | 20 |
Recent Clinical Trials for Uridine-5'-Diphosphate
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Utility of Pharmacogenomics of Psychotropic Medications | Oregon Health and Science University | Phase 4 |
| Citicoline Concentration in Human Vitreous | Fondazione G.B. Bietti, IRCCS | N/A |
| Citicoline Concentration in Human Vitreous | Istituto di Ricerca Neuroftalmologia S.r.l. | N/A |
Clinical Trial Summary for Uridine-5'-Diphosphate
Top disease conditions for Uridine-5'-Diphosphate
Top clinical trial sponsors for Uridine-5'-Diphosphate
US Patents for Uridine-5'-Diphosphate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Uridine-5'-Diphosphate | Start Trial | Compositions containing pufa and/or uridine and methods of use thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGIES (Cambridge, MA) | Start Trial |
| Uridine-5'-Diphosphate | Start Trial | Compositions containing PUFA and methods of use thereof | MASSACHUSETS INSTITUE OF TECHNOLOGY (Cambridge, MA) | Start Trial |
| Uridine-5'-Diphosphate | Start Trial | Process for purifying nucleoside-5'-diphosphates | Du Pont Merck Pharmaceutical Company (Wilmington, DE) | Start Trial |
| Uridine-5'-Diphosphate | Start Trial | Process for producing carbohydrates using .beta. 1,3-N-acetyl-glucosaminyltransferase | Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP) | Start Trial |
| Uridine-5'-Diphosphate | Start Trial | Joint lubrication with P2Y purinergic receptor agonists | Inspire Pharmaceuticals, Inc. (Durham, NC) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Uridine-5'-Diphosphate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Uridine-5'-Diphosphate | Australia | 2006251562 | 2025-05-23 | Start Trial |
| Uridine-5'-Diphosphate | Australia | 2006251569 | 2025-05-23 | Start Trial |
| Uridine-5'-Diphosphate | Brazil | PI0613274 | 2025-05-23 | Start Trial |
| Uridine-5'-Diphosphate | Brazil | PI0613303 | 2025-05-23 | Start Trial |
| Uridine-5'-Diphosphate | Canada | 2645645 | 2025-05-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
